These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 2503532)

  • 21. Functional characterization of hypothalamic hyperprolactinemia.
    Ferrari C; Rampini P; Benco R; Caldara R; Scarduelli C; Crosignani PG
    J Clin Endocrinol Metab; 1982 Nov; 55(5):897-901. PubMed ID: 6811605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of the dopamine agonist, lergotrile mesylate, on circulating anterior pituitary hormones in man.
    Thorner MO; Ryan SM; Wass JA; Jones A; Bouloux P; Williams S; Besser GM
    J Clin Endocrinol Metab; 1978 Aug; 47(2):372-8. PubMed ID: 45463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
    McCaa RE; Gillespie JB
    Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence that the beta-adrenergic system and prostaglandins stimulate renin release through different mechanisms.
    Hsueh WA; Goldstone R; Carlson EJ; Horton R
    J Clin Endocrinol Metab; 1985 Sep; 61(3):399-403. PubMed ID: 2991316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced response of plasma prolactin to metoclopramide during chronic converting enzyme inhibition.
    Dupont AG; Van der Nipen P; Van Steirteghem AC; Vanhaelst L
    Horm Metab Res; 1987 May; 19(5):212-5. PubMed ID: 3034757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
    Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
    J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal, hemodynamic, and hormonal responses to atrial natriuretic peptide infusions in normal man, and effect of sodium intake.
    Cuneo RC; Espiner EA; Nicholls MG; Yandle TG; Joyce SL; Gilchrist NL
    J Clin Endocrinol Metab; 1986 Oct; 63(4):946-53. PubMed ID: 2943757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exaggerated circadian variation in basal thyrotropin (TSH) and in the dopaminergic inhibition of TSH release in pathological hyperprolactinemia: evidence against a hypothalamic dopaminergic defect.
    Rodriguez-Arnao MD; Peters JR; Foord SM; Dieguez C; Edwards C; Gomez-Pan A; Hall R; Newcombe RG; Scanlon MF
    J Clin Endocrinol Metab; 1983 Nov; 57(5):975-80. PubMed ID: 6619271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reciprocal changes in active and inactive renin after converting enzyme inhibition in normal man.
    Goldstone R; Horton R; Carlson EJ; Hsueh WA
    J Clin Endocrinol Metab; 1983 Feb; 56(2):264-8. PubMed ID: 6296183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.
    Sawin CT; Hershman JM; Boyd AE; Longcope C; Bacharach P
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopaminergic modulation of aldosterone secretion in the normal menstrual cycle.
    Garcia-Robles R; Ruilope LM; Tovar J; de Pablos P; Parada J; Hurtado A; Miranda B; Fernandez Vazquez G; Rodicio JL; Sancho J
    J Clin Hypertens; 1987 Dec; 3(4):470-8. PubMed ID: 3134515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of angiotensin I converting enzyme inhibition and calcium channel blockade on plasma levels of active and inactive renin in conscious rabbits.
    Eisen V; Munday MR; Slater JD
    Biochem Pharmacol; 1987 Jul; 36(14):2331-5. PubMed ID: 2440439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of macroprolactinoma with the new potent non-ergot D2-dopamine agonist quinagolide and effects on prolactin levels, pituitary function, an the renin-aldosterone system. Results of a clinical long-term study.
    Nickelsen T; Jungmann E; Althoff P; Schumm-Draeger PM; Usadel KH
    Arzneimittelforschung; 1993 Apr; 43(4):421-5. PubMed ID: 8098604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential involvement of protein kinase C in basal versus acetylcholine-regulated prolactin secretion in rat anterior pituitary cells during aging.
    Pu HF; Liu TC
    J Cell Biochem; 2002; 86(2):268-76. PubMed ID: 12111996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of dexamethasone on prolactin and TSH responses to TRH and metoclopramide in man.
    Sowers JR; Carlson HE; Brautbar N; Hershman JM
    J Clin Endocrinol Metab; 1977 Feb; 44(2):237-41. PubMed ID: 402375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolactin and thyrotropin responses to thyrotropin-releasing hormone and metoclopramide in men with chronic alcoholism.
    Röjdmark S; Adner N; Andersson DE; Austern J; Lamminpää K
    J Clin Endocrinol Metab; 1984 Oct; 59(4):595-600. PubMed ID: 6434573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic evaluation of prolactin secretion in essential hypertension: evidence against hypothalamic-pituitary dopaminergic dysfunction.
    Lengyel AM; Vieira JG; Chacra AR; Abucham-Filho JZ; Lima MP; Ribeiro AB; Ramos OL
    J Clin Endocrinol Metab; 1982 Apr; 54(4):849-53. PubMed ID: 6801072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of serum prolactin on plasma adrenal androgens and the production and metabolic clearance rate of dehydroepiandrosterone sulfate in normal and hyperprolactinemic subjects.
    Schiebinger RJ; Chrousos GP; Cutler GB; Loriaux DL
    J Clin Endocrinol Metab; 1986 Jan; 62(1):202-9. PubMed ID: 2999177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of sodium balance and calcium channel-blocking drugs on plasma aldosterone responses to infusion of angiotensin II in normal subjects and patients with essential hypertension.
    Anderson GH; Howland T; Domschek R; Streeten DH
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1126-35. PubMed ID: 3760114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.